AZIYO BIOLOGICS INC's ticker is AZYO and the CUSIP is 05479K106. A total of 18 filers reported holding AZIYO BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,385 | -41.7% | 14,255 | -3.8% | 0.00% | – |
Q2 2023 | $34,963 | +128.1% | 14,815 | +45.9% | 0.00% | – |
Q1 2023 | $15,328 | -63.3% | 10,151 | +3.4% | 0.00% | – |
Q4 2022 | $41,739 | -37.7% | 9,821 | +4.5% | 0.00% | – |
Q3 2022 | $67,000 | -14.1% | 9,399 | -15.0% | 0.00% | – |
Q2 2022 | $78,000 | +105.3% | 11,063 | +73.3% | 0.00% | – |
Q1 2022 | $38,000 | -9.5% | 6,383 | -4.7% | 0.00% | – |
Q4 2021 | $42,000 | -6.7% | 6,698 | +2.7% | 0.00% | – |
Q3 2021 | $45,000 | -69.4% | 6,523 | -57.3% | 0.00% | – |
Q2 2021 | $147,000 | -77.3% | 15,280 | -67.5% | 0.00% | – |
Q1 2021 | $649,000 | +55.3% | 46,953 | +53.2% | 0.00% | – |
Q4 2020 | $418,000 | – | 30,644 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 1,655,184 | $2,499 | 1.96% |
PERKINS CAPITAL MANAGEMENT INC | 275,329 | $416 | 0.39% |
Prosight Management, LP | 196,443 | $296,629 | 0.14% |
Indie Asset Partners, LLC | 26,500 | $40,015 | 0.05% |
Knollwood Investment Advisory, LLC | 58,962 | $89,033 | 0.02% |
Alyeska Investment Group, L.P. | 214,343 | $323,658 | 0.00% |
Tower Research Capital LLC (TRC) | 5,134 | $8 | 0.00% |
US BANCORP \DE\ | 625 | $944 | 0.00% |
WELLS FARGO & COMPANY/MN | 56 | $85 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |